Cardiometabolic Flashcards
PFCMVPs associated with cardiometabolic disease (4)
Fe, Mg, CoQ10, MUFA/olive oil
from Cardiometabolic decision tree
Treatment considerations for insulin resistance
Cr, Vn (caution re: high dose long term), Mg; berberine, n3-fatty acids, MCT/MCFA, MUFA/olive oil; ALA for peripheral neuropathy, cinnamon
(from Cardiometabolic decision tree)
Treatment considerations for dyslipidemia
C:12 Lauric acid (increases TC & HDL, decreases TC/HDL), B3/B5, EPA/DHA +GLA, berberine, bergamot, garlic, red yeast rice
(from Cardiometabolic decision tree)
Treatment considerations for vascular disease
Mg/K; Arg, BH4, B2; taurine; pomegranate: lycopene, garlic; D3, K2-MK7
(from Cardiometabolic decision tree)
Treatment considerations for autonomic dysfunction
Meditation, breath Rx, biofeedback, HRV, adrenal support
from Cardiometabolic decision tree
Treatment considerations for coagulation disorders
ASA; B6, B12, FA; bromelain; nattokinase; vitamin E
from Cardiometabolic decision tree
Treatment considerations for immune & detox dysregulation
Probiotics, curcumin, quercetin, caloric restriction, vitamins C/E/A, ALA, NAC, resveratrol
(from Cardiometabolic decision tree)
What are some of the physiological interconnections between insulin, inflammation and adipocytes?
Think Gluco- and Lipotoxicity
- Excess nutrition/obesity increases adipocyte mass & death, which in turn increases release of inflammatory adipocytokines (TNF-alpha, IL-6, etc) & drives recruitment of macrophages from bone marrow into fat cells–> inflammation (paracrine response)
- High sugar & fat diet activates also TLR -> activates NF-kB and JNK pathways in adipocytes, hepatocytes and macrophages -> inflammation -> local & systemic insulin resistance
- Insulin resistance leads to fatty and inflamed liver and eventually insulin resistant muscle –> more inflammation
- Microbiome changes also increase leaky gut -> LPS and endotoxemia –> inflammation, inadequate SCFA, and further metabolic dysfunction
(from Dr. Saxena’s “Fire in the Hole” lecture)
What is the paracrine response to obesity, that drives insulin resistance in the adipocytes?
Increased resistin and decreased adiponectin (adipokines), release of pro inflammatory cytokines (TNF-alpha, IL-6, etc), and increased FFA -> leads to insulin resistance & inflammation within adipocyte
(from Dr. Saxena’s “Fire in the Hole” lecture)
What are some causes of insulin resistance?
Poor lifestyle, environmental toxins, mitochondrial dysfunction (b/c decreases insulin production), dysbiosis, altered body composition (increased BMI, WHR, WC, & body fat %), genetic predisposition
(from Dr. Saxena’s “Fire in the Hole” lecture)
What are the conventional “Should know” cardiometabolic lab tests & assessments?
BMI, WC, fasting BG & insulin, A1C, cholesterol or lipoprotein profile, hsCRP, CBC w/differential, homocysteine, GGT, vitamin B12, Mg, vit D25OH, CMP (esp AST, ALT), microalbumin creatinine ratio
What are some components of an expanded lipid panel?
LDL-P size and number, LDL pattern A vs B, HDL 2 vs 3, VLDL size
Modified (oxidized or glycated LDL),
ApoB (protein core of LDL/VLDL -bad), ApoA1 (protein core of HDL - good), ApoB:ApoA1 (target<0.8)
Lp-PLA2 (assoc w/oxLDL, inflammation & progression of atherosclerosis)
TGs, IDL (genetically determined and an independent risk factor), Lp(a)
What are some emerging cardiometabolic risk markers?
Oxidative stress (myeloperoxidase, F2I), CIMT, coronary artery calcium/CAC scoring, trimethylamine-N-oxide (TMAO;gut measure), omega-3 index, ASA resistance, aldosterone:renin ratio (ARR; 40+ suggests low renin HTN, <10 suggests high renin HTN)
How does TMAO respond with increasing CV risk?
Increases (via lipid dysregulation & macrophage function)
What is the relationship of TG level with insulin response?
Increased TG with excess insulin; precedes impaired fasting glucose.
TG/HDL ratio <3=normal; if >/=3 suggests insulin resistance
Which LDL particle pattern is preferred (A vs. B)
A; pattern B occurs with smaller and more dense LDL; increased LDL apo-B
What is the difference between HDL 2 & HDL 3?
HDL 2=large and buoyant (preferred), HDL 3= small & less protective
Which type of VLDL is associated with most risk?
VLDL 3 - most dense (compared to 1&2)
What are some conditions related to cardiometabolic dysfunction outside of CVD?
Obesity, sarcopenia, NAFLD, Type 2 & 3 DM, MetSx; Hormonal - E2 dominance/cancers (breast CA), PCOS, osteoporosis, men - decreased testosterone
How does insulin relate to increased risk of breast CA?
Increased insulin & IGF, decreased adiponectin -> inflammation; also increases estradiol & testosterone, decreases SHBG by increasing aromatase activity (testosterone binds SHBG preferentially)
What anthropometrics can be predictive for breast CA prognosis pre- and post-menopause?
BMI - post-menopausal
WHR - pre-menopause
Can focus on these for prevention
How does insulin relate to hormone changes in PCOS?
Increased insulin in ovaries -> increases testosterone, which binds to SHBG
In the natural history of Type 2 DM, what happens to: insulin resistance & secretion?
post-prandial and fasting glucose?
Insulin resistance increases before diagnosis and levels off
Insulin secretion increases until diagnosis and then decreases
Post-prandial glucose increases gradually then speeds up around diagnosis and beyond
Fasting glucose gradually increases toward diagnosis and beyond (increase is slower that post-prandial)
Note: incretin and B-cell function both declines over time
What are the differences between android obesity & gynoid obesity?
Android - apple shape; over fat, over VAT (visceral adipose tissue); assess w/WC & WHR
Gynoid - pear shape; over fat, over SAT (subcutaneous adipose tissue); assess with BIA (high %body fat, but normal WHR)
What are the risk levels associated with ApoE?
Apo E3 - least risk (prevalence 3/3 = 62%, 3/4 - 2%; most common)
Apo E2 - intermediate risk (2/3 - 1%, 2/3 - 10%; lower risk of elevated LDL, but higher TGs; associated with type III hyperlipoproteinemia)
Apo E4 - highest risk (3/4 - 20%, 4/4 - 5%)
ApoE is important for catabolism of TG-rich lipoproteins
What are some bacteria associated with CVD?
Brucella, Chlamydia pneumoniae, H pylori, P. gingivitis, hepatitis C
What type of fat is olive oil and what are some of its benefits on lipids?
n9 (oleic acid) MUFA; less LDL oxidation (compared to saturated fats), protects against LDL oxidation with high PUFA & SFA intake
What is the MOA or impact on lipids &/or CVD for each of the following nutraceuticals: trans-resveratrol Niacin Red Yeast Rice Turmeric ECGC Plant sterols Pomegranate Pantethine Probiotics Berberine Omega-3 FAs NAC Aged Garlic
t-resveratrol: blocks LDL uptake - decreases TC, TG & LDL
Niacin: decreases TC, LDL, apo-B & TGs; shifts type B-> type A
RYR: decreases LDL (HMGCoA inhibitor), decreases TG, but no significant change to TC or HDL
Turmeric: increases HDL, decreases TG & atherosclerosis
ECGC: HMGCoA inhibitor, decreases oxLDL & ap0B, increases LDL-receptors
Plant sterols: reduces TC & LDL, anti-inflammatory
Pomegranate: improves HDL function, platelet inhibitor
Pantethine: decreases TC, LDL, apoB & TGs; increases HDL and Apo-A1
Probiotics: reduces TC, LDL & TGs
Berberine: decreases PCSK9 activity & blood glucose; anti-inflammatory
Omega-3: decreases TG, COX-2 inhibition
NAC: blocks LDL uptake
Aged garlic: decreases CAC, plaque progression & hsCRP
What nutraceuticals increase HDL?
Curcumin, pomegranate, pantethine, omega-3, niacin
What are some precautions for niacin?
May increase blood glucose, homocysteine, uric acid & gout; S/E - rash, flushing, hyperpigmentation, gastritis, SVT & palpitations
What are the diagnostic criteria for metabolic syndrome?
3 of: increased waist circumference (M>40”, F>35”), BP >130/85 or on meds, FBG >/=100mg/dL, TG >/= 150, decreased HDL (M<40, F<50)
What are the ethno-specific criteria for waist circumference?
(USA, Asian/Hispanic, Euro/SS Africa/Middle East/Med)
USA: M >40”, F>35”
Asian/Hisp: M>35”, F>31”
Euro/SS Africa/Middle East/Med: M>37, F>31
What are the consequences of enhanced sympathetic response and reduced parasympathetic tone on CV indices?
HPA-dysfunction & SNS hyperactivity increases cortisol
Leads to; Enhanced coagulation, high RAAS, weight increase, insulin resistance, abnormal lipids, tachycardia, high BP, trophic effects, decreased HRV
How does nitric oxide benefit endothelial health?
Dilatation, growth inhibition, antithrombotic, anti-inflammatory, antioxidant
How is Angiotensin II detrimental to endothelial health?
Vasoconstriction, growth promotion, pro-thrombotic, pro-inflammatory, pro-oxidant
What factors can worsen endothelial function?
Sleep apnea, PCOS, Type 1 DM, malaria (improves with Arg), pre-eclampsia, high fat meals
What interventions can improve endothelial function?
Sildenafil (in men with T2DM), flavonoids improve endothelial dysfunction from high fat meals, cocoa flavanols (increase NO), Herbst Mandibular splint
What’s the difference between waking BP and sleeping BP? (systems involved)
Waking BP: controlled by sympathetic nervous system
Sleeping BP: controlled by RAAS (thus RAAS meds better at night and for nocturnal hypertension)
What are features of the Cardiometabolic food plan?
Modified Mediterranean diet, Low glycemic impact, targeted calories, balances blood sugar, high in fiber, low in simple sugars, balanced quality fats, condition-specific phytonutrients
What are the roles for Apolipoprotein E?
Required for clearance of chylomicrons and IDLs
Mediates cholesterol metabolism
Principal cholesterol carrier in the brain
(produced in the liver, macrophages & astrocytes)
Which ApoE profiles have increased risk of MCI & Alzheimer’s?
ApoE 3/4 and 4/4
Also increases risk of hyperlipidemia, Type 2 DM & CHD
Worse outcomes w/alcohol & smoking
What MTHFR SNPs are clinically relevant for CVD?
MTHFR A1298C, C677T
Heterozygous < homozygous
What are the mental benefits of Exercise?
Improves memory, increases hippocampus size, increases BDNF
What are the 4 parts of an Exercise Rx?
Frequency
Intensity
Time
Type